Die aktuelle Sklero AG - Literarturliste
Veröffentlichungen 2017 der Sklerotherapie

  1. Bush R, Bush P. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation. Phlebology. 2017; 32(7):496-500.
  2. Recke AL, Frendel A, Kahle B. Operative und postoperative Risiken kombinierter Eingriffe mittels perkutaner Phlebektomie und Schaumsklerosierung. Phlebologie 2017 46 2: 75-80.
  3. Murena-Schmidt RD. Ultraschallgesteuerte Schaumsklerosierung der Vena saphena parva Mehr als nur eine Therapiealternative? Phlebologie 2017 46 2: 60-62
  4. Kahle B, Friedrichsen L, Recke AL. Schaumsklerosierung bei geriatrischen Patienten. Phlebologie 2017 46 4: 224-226.
  5. Lal BK, Mallick R, Wright D. Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam. Phlebology. 2017; 32(5):342-354.
  6. Yin H, He H, Wang M, Li Z, Hu Z, Yao C, Wang J, Wang S, Chang G. Prospective Randomized Study of Ultrasound-Guided Foam Sclerotherapy Combined with Great Saphenous Vein High Ligation in the Treatment of Severe Lower Extremity Varicosis. Ann Vasc Surg. 2017; 39:256-263.
  7. Tan L, Wong K, Connor D, Fakhim B, Behnia M, Parsi K. Generation of sclerosant foams by mechanical methods increases the foam temperature. Phlebology. 2017; 32(7):501-505.
  8. Takai Y, Hiramoto K, Nishimura Y, Ooi K. Relationship between biochemical factors and skin symptoms in chronic venous disease. Arch Dermatol Res. 2017; 309(4):253-258.
  9. Gao Z, Zhang Y, Li W, Shi C. Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis. Dermatol Ther. 2018; 31(1).
  10. Yamaki T, Sasaki Y, Hasegawa Y, Osada A, Konoeda H, Hamahata A, Nozaki M, Sakurai H. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations. J Vasc Surg Venous Lymphat Disord. 2017; 5(5):707-714.